Use of the SYNTAX Score II to predict mortality in interventional cardiology A systematic review and meta-analysis

被引:12
作者
Yang, Hua [1 ]
Zhang, Li [2 ]
Xu, Chen Hong [1 ]
机构
[1] Yangtze Univ, Clin Med Coll 2, Jingzhou Cent Hosp, Dept Cardiol, Jingzhou 434020, Hubei, Peoples R China
[2] Yangtze Univ, Clin Med Coll 2, Jingzhou Cent Hosp, Dept Dermatol, Jingzhou, Hubei, Peoples R China
关键词
coronary artery disease; mortality; percutaneous coronary intervention; SYNTAX Score II; PERCUTANEOUS CORONARY INTERVENTION; ELEVATION MYOCARDIAL-INFARCTION; ARTERY-BYPASS SURGERY; LONG-TERM MORTALITY; CLINICAL-OUTCOMES; VALIDATION; DISEASE; REVASCULARIZATION; RATIONALE; DESIGN;
D O I
10.1097/MD.0000000000014043
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: As the SYNTAX Score has limitations, it should be replaced by another better angiographic tool. By comparing mortality that was observed following percutaneous coronary intervention (PCI) in patients who were allotted a low versus a high score, we aimed to systematically investigate mortality prediction using the SYNTAX Score II in Interventional Cardiology. Methods: Electronic databases were searched for relevant publications using the terms "SYNTAX Score II and percutaneous coronary intervention." The main outcome was all-cause mortality. This analysis was carried out by the RevMan 5.3 software [risk ratios (RRs) and 95% confidence intervals (95% CIs) were calculated]. Results: A total number of 9443 participants were enrolled for this analysis. As different studies reported different range of SYNTAX Score II, we further classified these scores range into 4 different groups: 17 <SS> 17, 20 <SS> 20, 22 <SS> 22, and 26 <SS> 26 appropriately. Results of this analysis showed that the risk of mortality in patients with a high SYNTAX Score II (SS>17) was significantly higher (RR: 2.65, 95% CI: 1.05-6.73; P=.04) than patients with a low SYNTAX Score II (SS<17). Even when participants with a low SYNTAX Score II (SS<20) were compared with patients who were assigned to a higher SYNTAX Score II (SS>20), a significantly higher risk of mortality was associated with a high SYNTAX Score II (RR: 3.73, 95% CI: 1.99-6.96; P=.0001). Conclusion: Following PCI, the risk of mortality was higher in those patients with a high SYNTAX Score II. The SYNTAX Score II might be considered as an important tool to predict mortality in Interventional Cardiology. Future research should further explore the benefits of this tool.
引用
收藏
页数:8
相关论文
共 28 条
[1]  
[Anonymous], CATHETER CARDIOVASC
[2]   Application of the SYNTAX score in interventional cardiology A systematic review and meta-analysis [J].
Bundhun, Pravesh Kumar ;
Sookharee, Yashna ;
Bholee, Anita ;
Huang, Feng .
MEDICINE, 2017, 96 (28)
[3]   Worse clinical outcomes following percutaneous coronary intervention with a high SYNTAX score A systematic review and meta-analysis [J].
Bundhun, Pravesh Kumar ;
Bhurtu, Akash ;
Huang, Feng .
MEDICINE, 2017, 96 (24)
[4]   Percutaneous Coronary Intervention, Coronary Artery Bypass Surgery and the SYNTAX score: A systematic review and meta-analysis [J].
Bundhun, Pravesh Kumar ;
Yanamala, Chandra Mouli ;
Huang, Feng .
SCIENTIFIC REPORTS, 2017, 7
[5]   Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial [J].
Campos, Carlos M. ;
Stanetic, Bojan M. ;
Farooq, Vasim ;
Walsh, Simon ;
Ishibashi, Yuki ;
Onuma, Yoshinobu ;
Garcia-Garcia, Hector M. ;
Escaned, Javier ;
Banning, Adrian ;
Serruys, Patrick W. .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2015, 86 (06) :E229-E238
[6]   Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II [J].
Campos, Carlos M. ;
van Klaveren, David ;
Farooq, Vasim ;
Simonton, Charles A. ;
Kappetein, Arie-Pieter ;
Sabik, Joseph F., III ;
Steyerberg, Ewout W. ;
Stone, Gregg W. ;
Serruys, Patrick W. .
EUROPEAN HEART JOURNAL, 2015, 36 (20) :1231-1241
[7]   Validation of the Ability of SYNTAX and Clinical SYNTAX Scores to Predict Adverse Cardiovascular Events After Stent Implantation: A Systematic Review and Meta-Analysis [J].
Chen, JiaYuan ;
Tang, Buzhou ;
Lin, YongQing ;
Ru, Ying ;
Wu, MaoXiong ;
Wang, Xiaolong ;
Chen, Qingcai ;
Chen, YangXin ;
Wang, JingFeng .
ANGIOLOGY, 2016, 67 (09) :820-828
[8]   Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease [J].
Escaned, Javier ;
Banning, Adrian ;
Farooq, Vasim ;
Echavarria-Pinto, Mauro ;
Onuma, Yoshinobu ;
Ryan, Nicola ;
Cavalcante, Rafael ;
Campos, Carlos M. ;
Stanetic, Bojan M. ;
Ishibashi, Yuki ;
Suwannasom, Pannipa ;
Kappetein, Arie-Pieter ;
Taggart, David ;
Morel, Marie-Angele ;
van Es, Gerrit-Anne ;
Serruys, Patrick W. .
EUROINTERVENTION, 2016, 12 (02) :E224-E234
[9]   Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II [J].
Farooq, Vasim ;
van Klaveren, David ;
Steyerberg, Ewout W. ;
Meliga, Emanuele ;
Vergouwe, Yvonne ;
Chieffo, Alaide ;
Kappetein, Arie Pieter ;
Colombo, Antonio ;
Holmes, David R., Jr. ;
Mack, Michael ;
Feldman, Ted ;
Morice, Marie-Claude ;
Stahle, Elisabeth ;
Onuma, Yoshinobu ;
Morel, Marie-angele ;
Garcia-Garcia, Hector M. ;
van Es, Gerrit Anne ;
Dawkins, Keith D. ;
Mohr, Friedrich W. ;
Serruys, Patrick W. .
LANCET, 2013, 381 (9867) :639-650
[10]   Predictive value of SYNTAX score II for clinical outcomes in cardiogenic shock underwent primary percutaneous coronary intervention; a pilot study [J].
Hayiroglu, Mert Ilker ;
Keskin, Muhammed ;
Uzun, Ahmet Okan ;
Bozbeyoglu, Emrah ;
Yildirimturk, Ozlem ;
Kozan, Omer ;
Pehlivanoglu, Seckin .
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2018, 34 (03) :329-336